Literature DB >> 30108720

Benzisoxazole: a privileged scaffold for medicinal chemistry.

K P Rakesh1, C S Shantharam2, M B Sridhara3, H M Manukumar4, Hua-Li Qin1.   

Abstract

The benzisoxazole analogs represent one of the privileged structures in medicinal chemistry and there has been an increasing number of studies on benzisoxazole-containing compounds. The unique benzisoxazole scaffold also exhibits an impressive potential as antimicrobial, anticancer, anti-inflammatory, anti-glycation agents and so on. This review examines the state of the art in medicinal chemistry as it relates to the comprehensive and general summary of the different benzisoxazole analogs, their use as starting building blocks of multifarious architectures on scales sufficient to drive human drug trials. The number of reports describing benzisoxazole-containing highly active compounds leads to the expectation that this scaffold will further emerge as a potential candidate in the field of drug discovery.

Entities:  

Year:  2017        PMID: 30108720      PMCID: PMC6072331          DOI: 10.1039/c7md00449d

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  63 in total

Review 1.  "Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining.

Authors:  Yu'ning Song; Wenmin Chen; Dongwei Kang; Qingzhu Zhang; Peng Zhan; Xinyong Liu
Journal:  Comb Chem High Throughput Screen       Date:  2014       Impact factor: 1.339

2.  Selective PPARgamma modulators with improved pharmacological profiles.

Authors:  Kun Liu; Regina M Black; John J Acton; Ralph Mosley; Sheryl Debenham; Ramon Abola; Meng Yang; Richard Tschirret-Guth; Lawrence Colwell; Cherrie Liu; Margaret Wu; Chuanlin F Wang; Karen L MacNaul; Margaret E McCann; David E Moller; Joel P Berger; Peter T Meinke; A Brian Jones; Harold B Wood
Journal:  Bioorg Med Chem Lett       Date:  2005-05-16       Impact factor: 2.823

3.  Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.

Authors:  Yuhao Li; Suping Wen; Bhavani Prasad Kota; Gang Peng; George Qian Li; Johji Yamahara; Basil D Roufogalis
Journal:  J Ethnopharmacol       Date:  2005-04-09       Impact factor: 4.360

4.  Pilot clinical investigation of risperidone in the treatment of psychotic patients.

Authors:  Y G Gelders; S L Heylen; G Vanden Bussche; A J Reyntjens; P A Janssen
Journal:  Pharmacopsychiatry       Date:  1990-09       Impact factor: 5.788

5.  Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles.

Authors:  J T Strupczewski; R C Allen; B A Gardner; B L Schmid; U Stache; E J Glamkowski; M C Jones; D B Ellis; F P Huger; R W Dunn
Journal:  J Med Chem       Date:  1985-06       Impact factor: 7.446

6.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Authors:  D P Hanger; K Hughes; J R Woodgett; J P Brion; B H Anderton
Journal:  Neurosci Lett       Date:  1992-11-23       Impact factor: 3.046

Review 7.  Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?

Authors:  Lawrence James Albers; Alessandro Musenga; Maria Augusta Raggi
Journal:  Expert Opin Investig Drugs       Date:  2008-01       Impact factor: 6.206

8.  Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Authors:  P A Janssen; C J Niemegeers; F Awouters; K H Schellekens; A A Megens; T F Meert
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

9.  Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: a structure-activity relationship study.

Authors:  S B Benaka Prasad; K Vinaya; C S Ananda Kumar; Sanjay Swarup; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-12-06       Impact factor: 3.850

10.  1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.

Authors:  Monish Jain; Chul-Hoon Kwon
Journal:  J Med Chem       Date:  2003-12-04       Impact factor: 7.446

View more
  6 in total

1.  Synthesis and process optimization of symmetric and unsymmetric barbiturates C5-coupled with 2,1-benzisoxazoles.

Authors:  João L Serrano; Pedro F Soeiro; Melani A Reis; Renato E F Boto; Samuel Silvestre; Paulo Almeida
Journal:  Mol Divers       Date:  2019-03-14       Impact factor: 2.943

Review 2.  Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.

Authors:  Harbinder Singh; Jatinder Vir Singh; Kavita Bhagat; Harmandeep Kaur Gulati; Mohit Sanduja; Nitish Kumar; Nihar Kinarivala; Sahil Sharma
Journal:  Bioorg Med Chem       Date:  2019-06-22       Impact factor: 3.641

3.  Amino-oxetanes as amide isosteres by an alternative defluorosulfonylative coupling of sulfonyl fluorides.

Authors:  Juan J Rojas; Rosemary A Croft; Alistair J Sterling; Edward L Briggs; Daniele Antermite; Daniel C Schmitt; Luka Blagojevic; Peter Haycock; Andrew J P White; Fernanda Duarte; Chulho Choi; James J Mousseau; James A Bull
Journal:  Nat Chem       Date:  2022-01-27       Impact factor: 24.274

Review 4.  More Than Resveratrol: New Insights into Stilbene-Based Compounds.

Authors:  Paulina Pecyna; Joanna Wargula; Marek Murias; Malgorzata Kucinska
Journal:  Biomolecules       Date:  2020-07-27

5.  Solvent-free synthesis of 3,5-isoxazoles via 1,3-dipolar cycloaddition of terminal alkynes and hydroxyimidoyl chlorides over Cu/Al2O3 surface under ball-milling conditions.

Authors:  Rafael A Hernandez R; Kelly Burchell-Reyes; Arthur P C A Braga; Jennifer Keough Lopez; Pat Forgione
Journal:  RSC Adv       Date:  2022-02-23       Impact factor: 3.361

Review 6.  Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis - a medicinal chemist perspective.

Authors:  Amaroju Suresh; Singireddi Srinivasarao; Yogesh Mahadu Khetmalis; Shashidhar Nizalapur; Murugesan Sankaranarayanan; Kondapalli Venkata Gowri Chandra Sekhar
Journal:  RSC Adv       Date:  2020-10-07       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.